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SUMMARY 
Primary keratinocyte cultures free of dermal fibroblasts were used to investigate the effect of 
varying cyclic AMP (CAMP) concentrations on epidermal cell function. Addition of lo-‘, lo-’ or 
10m5 M dibutyryl CAMP to plated cells (day I) results by day 5 in a dose dependent increase of 
[3H]TdR incorporation into DNA as determined by increases in both the labeling index and 
incorporation of “H label into an isolated DNA fraction. S-Bromo CAMP, another CAMP analogue, 
likewise induced keratinocyte proliferation. The proliferative response was dose and time depen- 
dent, and 5- to 6-fold increases in “H label incorporated into DNA were seen at day 6,8 and up until 
day 15 of culture. Moreover, elevation of cellular CAMP by addition of cholera toxin, an irreversi- 
ble stimulator of adenylate cyclase, also demonstrated a time dependent stimulation of [3H]TdR 
uptake into DNA and increased the labeling index. Specific histochemical staining for keratinaceo- 
us protein (Kreyberg technique) demonstrated that elevated CAMP levels also enhance the produc- 
tion of specialized (differentiated) epidermal cells. Determination of the level of CAMP and cyclic 
GMP (cGMP) by RIA of partially purified fractions of the cultures revealed that addition of 
8-bromo CAMP or cholera toxin to the cultures increased the levels of CAMP but not of cGMP. 
Addition of 8-bromo cGMP to the keratinocytes on day 1 at concentrations of 10mfi, 10-r or lo-# M 
had no effect on culture proliferation on days 4, 6 and 8, although qualitative changes in the 
electron microscopic pattern of the culture stratification and specialization were observed. The 
results indicate (1) both large and moderate increases in cellular CAMP levels induce keratinocyte 
culture proliferation and specialization in the absence of tibroblasts or dermal influences, (2) the 
quantitative enhancement of keratinocyte growth and specialization occurs without apparent 
participation of cGMP, (3) cGMP may be a qualitative effector of epidermal cell differentiation. 
Changes in cyclic nucleotides can influence 
the growth and differentiation (specializa- 
tion) of a variety of cell types. The direc- 
tion of proliferation-differentiation events 
associated with changes in cyclic AMP 
(CAMP) and cyclic GMP (cGMP) has been 
the subject of numerous investigations (see 
ref [ 1, 21 for review). The diversity of meth- 
odology and model systems [3-61, and 
unique individual cell type response to 
cyclic nucleotide fluctuations [7-l l] have 
probably resulted in a large portion of the 
reported discrepancies in the literature. 
Because of this, no unified hypothesis as to 
the role of CAMP and cGMP in eukaryotic 
cells can be formulated at this time. As a 
result, the cyclic nucleotide system of each 
individual cell system must be investigated, 
focusing on a cell’s own unique CAMP and 
cGMP regulatory mechanisms. 
The cyclic nucleotide modulatory system 
has been reported to be involved in several 
proliferation-differentiation disorders of 
human epidermis [12-151. The data re- 
sulting from cyclic nucleotide [16-181, and 
related enzyme(s) [ 16-191 and receptor [20] 
assays of epidermal biopsy material do sug- 
gest abnormalities in this regulatory system, 
although these systems are not technically 
amenable to delineate the functional aspects 
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of cyclic nucleotide modulation of the epi- 
dermis. Therefore, an in vitro epidermal 
cell culture system was used to define pos- 
sible cyclic nucleotide regulatory mechan- 
isms in epidermal function. The neonatal 
mouse keratinocyte cultures used in these 
experiments are free of co-cultured dermal 
fibroblasts and require minimal medium ad- 
ditives to demonstrate orderly and reprodu- 
cible proliferative patterns, stratification to 
6-8 cell layers and keratinocyte specializa- 
tion for greater than 4 weeks [21]. 
The present study provides evidence that 
both large and moderate increases in kera- 
tinocyte CAMP levels induce proliferation 
and culture stratification and specializa- 
tion. Added 8-bromo cGMP was found to 
have no apparent effect on cell proliferation 
and was observed to cause marked changes 
in keratinocytes specialization as observed 
by electron microscopy. 
MATERIALS AND METHODS 
Reagents 
Medium 199 (modified, Earle’s salts, glutamine), fetal 
calf serum, Penicillin and Streptomycin (P & S), Lux 
plastic coverslips and all phosphate buffered saline 
solutions (PBS) were obtained from Flow Labora- 
tories, Rockville, MD. Dibutyryl CAMP (db-CAMP) 
(N6,02-dibutyryl adenosine 3’ : 5’-cyclic monophos- 
phate; Bt,cAMP), I-bromo CAMP (I-bromoadenosine 
3’ : S’-cyclic monophosohate; 8-brcAMP), 8-bromo 
cGMP (&bromoguanosme 3’ : 5’-cyclic ‘monophos- 
phate; 8-BrcGMP), 8-bromo S’AMP, Ficoll 400 and 
trypsin type III were obtained from Sigma, St Louis, 
MO. Cholera Toxin (lot no. 0172) was a gift from 
C. E. Miller, Cholera program officer,? NIAD, 
Bethesda, Md. Methylisobutylxanthine (MIX) was 
supplied by Searle and Co., Chicago, Ill. Saffron 
(Chroma-Gesellschaft) is distributed by Roboz Sur- 
gical Inst. Co., Washinaton. D.C.. and other histo- 
logical stains were from Matheson, Coleman and Bell, 
East Rutherford, N.J. AG 5OW-X8 (100-200 mesh, H+ 
form) and AG l-X2 (200-400 mesh, Cl- form) were 
purchased from Bio-Rad Laboratories, Richmond, 
Ca ‘251-labeled SCAMP-TME and ScGMP-TME ligand 
for radioimmunoassay (RIA) were supplied by Col- 
laborative Res, Boston. Mass. The anti-CAMP (titer: 
I-5000) and anti-cGMP (titer, I-20000) sera ‘were 
produced in rabbits and show high specificity. Uranyl 
acetate was obtained from Mallinckrodt, St Louis, MO, 
and Epon 812 from Ladd, Res., Burlington, Vt. [3H]- 
TdR (60 Ci/mMol) was purchased from New England 
Nuclear, Boston, Mass. Corning Plastic products 
(Corning, N.Y.) were used in all phases of cell isola- 
tion and growth. 
Epidermal cell cultures 
The primary keratinocyte cultures were prepared as 
previously described [2l]. Full thickness skin from 
40-60 neonatal BALB/c mice is trypsinized (0.25%) 
for I h at 37°C. The epidermal cells that are isolated 
after manual separation of the dermis from the epi- 
dermis are further purified from any dermal tibroblasts 
and debris by use of a discontinuous Ficoll gradient. 
2~ 10” trvpan-blue excludina cells are olatedlcm’ in 
medium 199 plus 13 % fetal calf serum (FCS) and con- 
taining 50 IU/ml of penicillin and 50 ug/ml of strepto- 
mycin. The cells are grown in 5% CO, in air gassing 
at 33°C. The medium is changed everv second dav. 
The dissociation procedure were designed to elim- 
inate any co-cultured libroblasts. The absence of 
dermal fibroblasts was shown by use of the leucine 
aminopeptidase histochemical techniaue which can 
detectone libroblast/2~ 10” keratinocytks [21]. 
The CAMP and cGMP analoaues, and cholera toxin 
were added to the cultures on day 1 unless otherwise 
specified and with each medium change. 
Methods of assay 
To quantitate the incorporation of [:‘H]TdR into kera- 
tinocyte culture DNA, the monolayers were pulsed for 
6 h with 1 &i/ml of 60 Ci/mMol of [3H]TdR. After 
rinsing the monolayers twice with cold Dulbecco’s 
PBS, the cells were scraped with 4 ml of cold 6% 
trichloroacetic acid (TCA). The precipitate was 
washed twice with 2 ml of 6 % TCA. dne ml of the 6 % 
TCA fraction was counted to determine the [3H]TdR 
acid-soluble fraction. Unless specified, the cpm of 3H 
label in the acid-soluble fraction of the experimental 
cells was that of the control. The 6% TCA pellet was 
hydrolyzed with 3% PCA and aliquots of the super- 
natant were counted to auantitate the 3H label into 
DNA and assayed calorimetrically for DNA [22]. 
The RIA for CAMP and cGMP were done as re- 
ported [l7]. The partially purified CAMP and cGMP 
fractions were acetylated as reported by Harper & 
Brooker [23]. Use of 3 different dilutions, cyclic nu- 
cleotide phosphodiesterase digestion of samples (prior 
to acetylation) and internal standards verified the ac- 
curacy of the assays. The ‘2SI-labeled l&and was ob- 
tained from Collaborative Res., and the anti-CAMP 
and cGMP sera was produced in rabbits as described 
by Steiner et al. [24]. 
All fractions and assays were counted usingdioxane- 
naphthalene based or toluene-ethoxyethanol based 
(RIA) scintillation fluid in a Packard Tri-carb scintilla- 
tion counter (60% efficiency for tritium). 
Autoradiography 
Cells were grown on Lux coverslips and labeled for 
18-20 h with I &i/ml of f3H1TdR. After fixation. the 
coverslips were processed for autoradiography as de- 
scribed [2l]. 
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Cholera toxin study in 13 % mnd Table 1. Effect of db-cAMP on kerutinocyte 
I%FCS proliferation 
The medium was removed from day 1 cells and me- 
dium 199 plus 1 R FCS containing 50 PM MIX was 
added to one set of experimental T-25 flasks. Medium 
199 plus 13% FCS plus 50 FM MIX was added to the 
other set of experimental flasks. Either 13% or I % 
Medium 199 was added to the control flasks (no MIX). 
The cholera toxin was added to each of the 13% and 
I % FCS experimentals. Enough FCS was added to the 
control and experimental flasks in the I %a FCS me- 
dium to yield a tinal concentration of 13% after 3 h. 
The cholera toxin and MIX were readded with each 
medium change. 
Cont. Incorporation” 
added D= I :‘H into DNA Autoradiography* 
db-CAMP cpm/pCLg DNA labeled cells/S00 
None 
1 O-:’ M 
I 13lk 84 42.5+ 2 
4 149kl20 107.6f19P=0.01 
Histochemicul stuins und electron 
microscopy 
IOP M 2 272+149 131.0~27P=0.004 
IO-” M I S8Sk 64 53.0fll N.S. 
Na Butyute 
None 288+ 9 Not done 
IO-:’ M 204k20 Not done 
’ Six hour terminal labeling on day 5,5 &i/flask [YH]- 
TdR, 50 Ci/mMol spec. act. DNA extracted with 3% 
PCA after 6% TCA precipitation. Mean2 S.E.M. of 
quadruplicate flasks. 
’ Twenty hour terminal labeling with 5 &i/flask [“HI- 
TdR, day 4 to 5. Mean + S.E.M. of triplicate slides 
from duplicate T-25 flasks. Student’s t-test. two- 
sided. 
The Kreyberg stain was done as reported [21]. After 
fixation, the cultures and cryostated sections of neo- 
natal mouse skin were stained with Mayer’s hema- 
toxylin. 1% aqueous erythrosin and a saffron solution. 
The basal cell layer of the whole skin shows only nu- 
clear blue-grey stain while the spinous. granular and 
stratum corneum layers (non-proliferative and spe- 
cializing cells) stain a vivid red color (erythrosin). As 
the cultures stratify and specialize in vitro, the red- 
staining material developes [21]. 
For electron microscopy, the cultures were treated 
as previously reported [21]. Sections were examined 
with Philips 300 electron microscope at 60 kV. 
RESULTS 
effect of db-CAMP and 8-bromo 
CAMP on kerutinocyte 
proliferation 
Dibutyryl CAMP was added to the cultures 
on day 1 to give a final concentration of 
lo-“, 10ml or 10-j M. Table 1 presents the 
data showing the effect of this CAMP ana- 
logue on the incorporation of [3H]TdR into 
DNA as determined by quantitation of 3H 
label into cellular DNA and autoradio- 
graphy. As shown, db-CAMP stimulated 
keratinocyte proliferation as assayed by 
cpm of 3H/pg DNA in a dose dependent 
manner: lo-” M db-CAMP induced a 3.7- 
fold and 10m4 M db-CAMP produced a 2.0- 
fold stimulation while lop5 M concentration 
of the analogue had minimal effect at this 
time point (D=5). Autoradiography also in- 
dicated that the dibutyryl analogue stimu- 
lated keratinocyte proliferation. However, 
this technique cannot be used to quantitate 
a dose response since the 4-5 cell layers 
that develop by this time absorb the radia- 
tion emitted by the 3H label in the DNA be- 
fore it can interact with the emulsion. 
lo-” M Na butyrate did not effect keratino- 
cyte proliferation (table 1). Fig. 1 shows the 
results of a series of overlapping (days) time 
and dose response experiments using the 
8-bromo CAMP analogue. As presented, 
lo-” M 8-bromo CAMP had no effect on 3H 
incorporation into cellular DNA 3 and 6 h 
after addition. By day 2, which is 24 h after 
the 8-bromo analogue was added, 10e3 and 
lo-” M 8-bromo CAMP increased keratino- 
cyte proliferation while the 10F5 M con- 
centration was not effective until day 6, 5 
days after exposure to the CAMP analogue. 
The stimulatory effect of 8-bromo CAMP at 
these concentrations has been routinely ob- 
served (data not presented) until day 15 of 
culture (the last time point studied). 10e2 M 
8-bromo CAMP inhibited keratinocyte pro- 
liferation, in concert with monolayer de- 
struction. 
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Fig. 1. Abscissa: time in culture (days); or&are: c/c 
control=cpm/pg DNA/experimental/cpm/~g DNA 
control. tS, 10m3 M; n , 1OW’ M; R. 10m5 M 8-Bromo 
CAMP. 
Effect of 8-bromo CAMP on keratinocyte prolifera- 
tion. Control value, 100%. Bar, mean k S.E.M. of 
separate experiments; the number over each bar des- 
ignates the n number of experiments, each con- 
sisting of triplicate T-25 flasks. Percent control repre- 
sentation of the data is used to facilitate the presenta- 
tion and statistical analysis of the data since the graph 
presents the results from 5-6 different cell prepara- 
tions. 
Effect of cholera toxin 
Since S’AMP and adenosine elevate the 
levels of CAMP in mouse [25], in human [26] 
and pig [27] epidermis and in the neonatal 
mouse cultures (Duell, unpublished re- 
sults), this nucleotide and nucleoside and 
their analogues could not be used to test the 
specificity of the CAMP analogue effects. 
Cholera toxin is an irreversible stimulator 
of adenylate cyclase, the enzyme that cata- 
lyzes the formation of CAMP from ATP [28, 
291; therefore, it was used to elevate the 
intracellular levels of keratinocyte CAMP. 
Fifty PM MIX (I-methyl-3-isobutyl- 
xanthine) was also added to inhibit cyclic 
nucleotide phosphodiesterase activity and 
thereby maintain the elevated cellular 
CAMP levels [30]. 
Since Guerrant et al. [29] reported that 
CHO cell response to cholera toxin was 
maximal in 1% FCS concentrations, the 
magnitude of cholera toxin induced CAMP 
(and cGMP) changes and effect on keratino- 
cyte proliferation when added in the pres- 
ence of either 1% or 3 % FCS (first 3 h) 
was ascertained. As presented in table 2, 
1 pg/ml cholera toxin in 50 PM MIX in- 
creased CAMP levels approx. 7- to S-fold 
3 h to 72 h after addition; this plateauing 
effect is similar to that reported by Guerrant 
et al. in a number of cell lines [29]. The per- 
cent of FCS in the medium did not signifi- 
cantly alter the magnitude of the observed 
change in CAMP or the increase in keratino- 
cyte proliferation that was observed after 48 
and 72 h (approx. 2-fold, table 2). No 
changes in cGMP were observed. All fur- 




Fig. 2. Abscissu: time in culture (days); or- 
dinate: cpm/&DNA. H, Control; R, SO 
pglml; a, 0.5 rig/ml; BP, 50 nglml; @I, I .O pg/ 
ml cholera toxin. 
Effect of cholera toxin on keratinocyte 
proliferation. Bars, mean? S.E.M. of tri- 
plicate flasks, all part of one experimental 
series. All experimental contained 50 PM 
MIX. 
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Table 2. Changes in kerutinocyte cyclic nucleotide content effected by cholera toxin and 
8-bromo CAMP 
Addition 
13% FCS 1% FCS 
Time FmoW 
(hours) cpm” y Pmols CAMP” ” Fmols cGMP” (1 cpmY Pmols CAMP” cGMP 
Control 3 - 
I ct’ /.Lg 3 - 
Control 48 5 202&856 
1 !-%ct 48 8 315k982 
Control 12 669233 
1 ct PLg 72 I 303+54 
Control’ 96 530+57 
50 ct ng 96 560+26 
X-BrcAMP 
ImM 96 I 371&4 
0.299+0.038 26.5kO.5 - 0.560d 16.0” 
2.17+0.39 22.Ok4.0 - 4.83LO.88 21 .Of3.0 
0.40+0.12 17.5+ 12.0 3 682?222 0.39d 37.0+ 1.0 
3.29kO.044 19.7* 4.0 6 791+808 3.36+0.90 22.oi5.0 
0.296kO.09 13.0* I.0 666k52 0.532?0. I I6 I2.Oi I .O 
2.56k0.13 8.Ok5.0 I 228+-I57 I .66+0.090 7.Ok2.0 
0.323+0.056 10.0+2.0 
I. I l7LO.240 7.0? I .o 
21.50+3.20 10.0&2.0 
‘I 6 h terminal labeling with 1 &i/ml [“H]TdR, 60 Ci/mMol; Mean & S.E.M. of triplicate Petri dishes. 
b Mean + S.E.M. of duplicate or triplicate flasks. 
’ Mean ?Y S.E.M. of duplicate or triplicate flasks. 
‘l Mean of quadruplicate RIA determinations of one sample. 
“ ct. cholera toxin+50 pm MIX. 
’ Separate experimental series from above. 
After 3 h exposure to the CT. the cells in I % FCS were restored to I3 rii FCS since this concentration is 
required for cell growth. 
‘i Each of these measures is calculated per pg DNA. 
ther cholera toxin experiments were there- 
fore conducted using 13 % FCS. 
Another concentration of cholera toxin, 
50 nglml, was shown to increase CAMP 
levels approx. 3.5fold after exposure of 
the cells to the toxin for 4 days. No changes 
in cGMP were observed (table 2). Also 
presented in table 2 is the result of the 
CAMP and cGMP RIA of keratinocyte cul- 
tures treated with 1 mM 8-bromo CAMP. 
The 6% TCA supernatant containing the 
cyclic nucleotides, and other nucleotides 
and nucleosides was ether extracted, was 
precipitated with ZnAc-Na,CO, and sub- 
jected to Dowex 50x8 and Dowex 1 x2 
chromatography [ 171, which separates 
CAMP from cGMP and both from the S- 
bromo CAMP analogue. One mM 8-bromo 
CAMP was found to increase the CAMP 
levels (from a control value of 0.32kO.056 
to 21.5Ok3.2 pmol/pg DNA, table 2), a 66- 
fold increase. There was no change in the 
levels of cGMP. 
The results of a time and dose study using 
four cholera toxin concentrations in the 
Table 3. Effect of 8-bromo cGMP on keru- 
tinocgte proliferation (cpmlpg DNA) 
Days in culture 
4 6 8 
8-Bromo cGMP 
None l47+27 357+61 205kll 
IO-” M l65? 4 428+36 296+40 
IO-’ M 15Ok32 216?44 185&24 
IOW M 92* I3 217i50 234221 
8-Bromo CAMP 
None 758+103 28l+ 24 226?27 
lO-3 M 3 36l& 57 753+l I5 I ll5t-50 
lO-q M I 599+lOO 687+ IO I 042+29 
lO-5 M 868k I6 335+ 57 5485 I3 
Mean &. S.E.M. of quadruplicate 60 mm Petri dishes. 
Drugs added D= I. 
E.\-l’ (‘c/i Rr\ /‘O , IY7Y) 
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presence of 50 PM MIX is presented in fig. 
2. I .O pg/ml cholera toxin which stimulated 
the CAMP level approx. g-fold, 50 rig/ml 
cholera toxin which was shown to increase 
CAMP at day 4, plus 0.5 rig/ml and 50 pg/ml 
concentrations were added on day 1. The 
results, as shown in fig. 2, indicate that 
cholera toxin demonstrates a time depend- 
ent effect although a longer time course was 
necessary for stimulation of keratinocyte 
proliferation by the day 5 time point, which 
is 4 days of culture in the toxin. The results 
indicate that g-fold, 3-fold and possibly 
lower increases in cellular CAMP (with the 
0.5 rig/ml and 50 pg/ml doses) can cause 
from 3- to IO-fold increases in keratinocyte 
proliferation (fig. 2). No obvious dose re- 
sponse was observed. 
The 1 pg/ml concentration of cholera 
toxin also increased the labeling index from 
14% to 35% (p=O.OOS) at day 5. 
Effect of cGMP on keratinocyte 
proliferation 
The 8-bromo CAMP analogue and cholera 
toxin in the presence of MIX stimulate 
keratinocyte proliferation and increase the 
Fig. 3. Electron micrographs of (a) control keratino- 
cyte cultures; (b) keratmocytes treated with I x 10m3 M 
Cbromo CAMP; (c) cultures treated with 1 x IO-’ M 
8-bromo cGMP; and (d) of cells exposed to I x IO-’ M 
8-bromo S’AMP. The drugs were added on day I and 
the cultures were fixed on day 5. The controlculture 
((I) has 3 cell layers with well formed nuclei [?I], and 
desmosomal complexes [d]. The 8-bromo CAMP 
treated cultures (h) consist of 8 cell layers, including 
the terminally differentiated upper cell which pos- 
sesses a thickened cell membrane [m] and aggregated 
tibrils [u]. The 8-bromo CAMP cultures (b) demon- 
strate desmosomal complexes [d] and cross- and 
length-wise fibrils Ifl. The 8-bromo cGMP treated cul- 
tures (c) consist ofl5 cell layers. The bottommost cell 
(against the plastic) has dark and well defined fibrils 
cfl which do not appear in the controls at any time 
point. The cell layers are much thicker, possess des- 
mosomal complexes [d] that appear much denser than 
in the control keratinocytes, large numbers of aggre- 
gated fibrils [o] and an abundance of free ribosomes 
[r]. The 8-bromo S’GMP at a IO-‘M concentration had 
no effect on the cultures. Bar, 0.2 pm. x47000. 
Ia-7YlXOh 
CAMP levels of the cultures without any ap- 
parent increase in the cGMP levels (table 
2). It was possible, however, to postulate a 
very brief increase in keratinocyte cGMP or 
an intracellular shift in cGMP levels [31] to 
account for the observed stimulation since 
increased levels of cellular CAMP could be 
effecting cGMP concentrations (tempo- 
rarily) or localization. To investigate this 
possibility, 10e6, lo-’ and lO-8 8-bromo 
cGMP was added to the cultures on day 1 
and the rate of 3H uptake into DNA was 
quantitated on day 4, 6 and 8. As shown in 
table 3, 8-bromo cGMP at these concentra- 
tions had no effect on [3H]TdR uptake into 
DNA. A time and dose response for the 
8-bromo CAMP analogue from another ex- 
perimental set is also presented to contrast 
the different effects of the two cyclic nu- 
cleotides. 
Electron microscopy and 
histochemistry 
Simultaneous with the stimulation of kera- 
tinocyte proliferation, 8-bromo CAMP aug- 
ments the specialization of the cultures as 
demonstrated by the greatly increased ap- 
pearance of Kreyberg stainable (red) upper 
cells layers after 9-14 days of growth in the 
8-bromo analogue. 
Fig. 3 presents electron micrographs of 
control (a), a 8-bromo CAMP-treated cul- 
tures (b ; 1 mM) as well as IO-’ M 8-bromo 
cGMP-treated (c) and lo-’ M 8-bromo 
S’GMP-treated (d) keratinocytes. The con- 
trol keratinocyte cultures, as shown in fig. 
30, consist of 3 cell layers; desmosomal 
complexes which are characteristic of the 
epidermal cells of the skin, conjoin the kera- 
tinocytes and there are a few isolated fibrils 
in the uppermost cells, a characteristic of 
day 5 cultures [21]. The 1 mM 8-bromo 
CAMP-treated cultures (b) consist of 8 cell 
layers, including the uppermost terminally 
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differentiated cell which contains a thicken- 
ed cell membrane (m), electron dense amor- 
phous aggregated fibrils without a limiting 
membrane (a) and a degenerated nucleus. 
Desmosomal complexes are evident as is 
the presence of cross and length-wise fi- 
brils, all characteristic of a more developed 
culture [21]. The effect of the 8-bromo 
CAMP analogue is not the result of a tempo- 
rary 2-3 day ‘speeding up’ of the culture 
proliferation-specialization pattern time 
course since the analogue has been ob- 
served to augment proliferation and specia- 
lization from day 34 to 15 of culture. 
Fig. 3c presents cultures treated with 
lop7 M 8-bromo cGMP (day 5). The cul- 
tures consist of 5 cell layers which are much 
‘thicker’ than the control or 8-bromo CAMP 
treated cultures. Thick fibrils (f) run along 
the bottom-most cell (against the plastic), 
the desmosomal complexes (d) appear very 
dense, and large amounts of aggregates (a) 
and fibrils (f) are seen. In addition, large 
numbers of free ribosomes are present. This 
observation, when coupled with the in- 
creased size of the cells, suggest that the 8- 
bromo cGMP augmented keratinocyte pro- 
tein synthesis in a manner possibly unique 
to cGMP, since none of our observations of 
control cultures from day 1 to day 30-3.5 
[21] have disclosed keratinocyte layers with 
this specialization and stratification pattern. 
8-Bromo S’GMP at a 1O-7 M concentration 
had no effect on the EM morphology of the 
cultures (fig. 3d). 
DISCUSSION 
The role of CAMP as a positive effector of 
cell proliferation has been the subject of 
many reports (see [ 1, 21 for reviews), and 
CAMP has been recently demonstrated to 
be a mitogenic signal for cultured rat 
Schwann cells [32] and a possible DNA syn- 
EX/J Cd Re.> I20 (1979) 
thesis initiator signal for BALB/3T3 cell cul- 
tures [33]. The data presented in this report 
indicates that both high and moderate in- 
creases in keratinocyte CAMP levels can 
stimulate proliferation and specialization, 
and that cGMP can be a qualitative effector 
of epidermal cell differentiation, both func- 
tional events occurring without involve- 
ment of tibroblastic or dermal influences. 
These results are in agreement with the 
hypothesis that CAMP and cGMP can be 
metabolic regulators of epidermal prolifera- 
tion and specialization [34]. 
Several published investigations report 
that CAMP analogues and several drugs that 
can elevate CAMP, inhibited human epider- 
ma1 cells [35, 361 and epidermal mitosis in 
an in vitro mouse ear assay [37] during the 
G2 portion of the cell cycle, indicating that 
CAMP can be a G2 cell blocker in adult epi- 
dermis. In an in vivo model, Aso et al. [38] 
demonstrated that retinoic acid induced in- 
creases in mitotic activity and changes in 
specialization of adult guinea pig ear skin 
are associated with increases in both the 
CAMP and cGMP content of the tissue. 
Delescluse et al. [39] report that lo-*- 
10-” M db-CAMP inhibits [3H]TdR uptake 
into guinea pig epidermal cell cultures 1 day 
after addition. Concomitant with the inhibi- 
tion is an induction of differentiation of the 
cells after 6-8 days as reported by Deles- 
cluse et al. [40]. The difference between 
these studies [39, 401 in adult guinea pig 
ear skin that link CAMP with inhibition of 
proliferation and enhanced differentiation, 
and the results reported here, i.e., a stimu- 
lation of proliferation and specialization ob- 
served with increased CAMP levels, could 
reflect variations in in vitro models and 
techniques. Such variations may be species 
variation, adult versus neonatal cells, dis- 
sociation procedures, etc. 
The use of this in vitro epidermal cell 
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system has allowed direct study of the dif- 
ferential effects of elevated CAMP levels 
and a cGMP analogue on keratinocytes free 
from dermal influences. The observation 
that cGMP can qualitatively change the 
electron microscopic morphology of the 
keratinocytes at 10d7 M concentration with- 
out any apparent stimulatory effect was not 
expected since an increase in cellular cGMP 
levels has been postulated to be involved in 
the proliferative events of the epidermis 
[16, 341. The data suggests that one type of 
epidermal cell proliferation-specialization 
program (at least, in vitro) is associated 
with elevated CAMP levels while a type of 
specialization function can be effected by 
cGMP. 
Other agents can effect the proliferation- 
specialization pattern of primary epidermal 
cell cultures derived from neonatal mice. 
Investigations reported by Yuspa et al. [41] 
which we have verified (data not presented) 
demonstrate that lop7 M TPA (12-O-tetra- 
decanoyl-phorbol-13-acetate), a tumor pro- 
moter, stimulates keratinocyte culture pro- 
liferation with an almost complete abolition 
of specialization and differentiation. This 
dose of TPA induces a proliferative re- 
sponse not associated with an increase in 
CAMP or cGMP at 2, 5 and 10 min, 1 and 
3 h, and 3 days after exposure of the cells to 
the drug (Marcelo, unpublished results). 
Yuspa et al. [42] reported that another epi- 
dermal cell modifier, retinyl acetate, modu- 
lates neonatal mouse epidermal cell cul- 
tures by decreasing the labeling index, and 
by altering the course of specialization 
(verified by us, data not presented). There 
are no changes in CAMP and cGMP levels 
during the initial 3 h of exposure to the drug 
(Marcelo, unpublished data). These studies 
by other investigators and ourselves dem- 
onstrate modulation of keratinocyte pro- 
liferation and specialization without any ap- 
parent change in the intracellular cyclic nu- 
cleotide concentrations. 
The results presented in this report de- 
scribe the stimulation of a keratinocyte 
proliferation-specialization pattern by in- 
creases in cellular CAMP levels and alter- 
ations of specialization patterns by a cGMP 
analogue. Retinyl acetate and TPA have 
been shown to also alter these functions, 
without any apparent change in the CAMP 
or cGMP level. These results could allow 
the formulation of the hypothesis that the 
epidermal cell, at least in vitro, can undergo 
cell cycle-functional events associated with 
alterations in the cyclic nucleotide levels; 
and can undergo other events seemingly in- 
dependent of changes in these modulations. 
However, recent investigations by Koide 
et al. [31] have demonstrated that altera- 
tions in intracellular distribution of cGMP 
and guanylate cyclase can be found in liver 
cells undergoing regeneration, suggesting 
that no change in measurable CAMP or 
cGMP cell content does not rule out a role 
for cyclic nucleotides in any one kind of 
proliferation-specialization event. There- 
fore, while association of changes in CAMP 
or cGMP with specific proliferation pro- 
grams in the skin is an attractive hypo- 
thesis, assessment of the validity of this 
premise must await further investigations 
which are presently underway. 
A preliminary report of this work was presented at the 
Plenary session of the meeting of the Society of In- 
vestigative Dermatology (J invest dermatol 70 (1978) 
221. 
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